مقالات International Journal of Health Policy and Management، دوره 5، شماره 41.Collaboration and Co-Production of Knowledge in Healthcare: Opportunities and Challenges2.Priority Setting for Improvement of Cervical Cancer Prevention in Iran FullText3.Vaccine Wastage Assessment After Introduction of Open Vial Policy in Surat Municipal Corporation Area of India4.Socio-economic Aspects of Health-Related Behaviors and Their Dynamics: A Case Study for the Netherlands FullText5.Policy Options to Reduce Fragmentation in the Pooling of Health Insurance Funds in Iran FullText6.Challenges Facing Healthwatch, a New Consumer Champion in England FullText7.Whistle Blowing: A Message to Leaders and Managers; Comment on “Cultures of Silence and Cultures of Voice: The Role of Whistleblowing in Healthcare Organizations”8.A Wicked Problem? Whistleblowing in Healthcare Organisations; Comment on “Cultures of Silence And Cultures of Voice: The Role of Whistleblowing in Healthcare Organisations”9.Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”10.Political Impetus: Towards a Successful Agenda-Setting for Inclusive Health Policies in Low- and Middle-Income Countries; Comment on “Shaping the Health Policy Agenda: The Case of Safe Motherhood Policy in Vietnam”11.Advancing Global Health – The Need for (Better) Social Science; Comment on “Navigating Between Stealth Advocacy and Unconscious Dogmatism: The Challenge of Researching the Norms, Politics and Power of Global Health”12.Considering the Future of Pharmaceutical Promotions in Social Media; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”13.Still the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”14.Learning Valuable Perspectives on Improving the World’s Health Through the Post-۲۰۱۵ Development Agenda: A Response to Recent Commentariesتاریخ نمایه سازی مقالات: 16 مرداد 1403 - تعداد نمایش اطلاعات ژورنال: 4 آرشیو سال 1395 International Journal of Health Policy and Managementدوره: 5شماره: 9دوره: 5شماره: 8دوره: 5شماره: 7دوره: 5شماره: 6دوره: 5شماره: 5دوره: 5شماره: 4دوره: 5شماره: 3دوره: 5شماره: 2دوره: 5شماره: 1آرشیو سال 1394 International Journal of Health Policy and Managementدوره: 4شماره: 12دوره: 4شماره: 11دوره: 4شماره: 10دوره: 4شماره: 9دوره: 4شماره: 8دوره: 4شماره: 7دوره: 4شماره: 6دوره: 4شماره: 5دوره: 4شماره: 4دوره: 4شماره: 3دوره: 4شماره: 2دوره: 4شماره: 1آرشیو سال 1393 International Journal of Health Policy and Managementدوره: 3شماره: 7دوره: 3شماره: 6دوره: 3شماره: 5دوره: 3شماره: 4دوره: 3شماره: 3دوره: 3شماره: 2دوره: 3شماره: 1دوره: 2شماره: 4دوره: 2شماره: 3دوره: 2شماره: 2دوره: 2شماره: 1آرشیو سال 1392 International Journal of Health Policy and Managementدوره: 1شماره: 4دوره: 1شماره: 3دوره: 1شماره: 2دوره: 1شماره: 1